EUVIMEDEUVIMED entdecken
Crossref

HIV-1 infection in South Kivu (Democratic Republic of Congo): high genotypic resistance to antiretrovirals

Alexandra Duhant, Byabene Kusinza, Claire Tantet, Basimane Bisimwa, Mathilde Gare, Bihehe Masemo, Chakib Alloui, Mukanire Ntakwinjan, Frédéric Mechai, Minh Patrick Le iD, Athenaïs Gerber, Balthazar Muhigirwa und 5 weitere

Journal of Antimicrobial Chemotherapy · 2023

DOI: 10.1093/jac/dkad163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Alexandra Duhant und 16 weiteren Autor:innen. Beteiligte Einrichtung: APHP, Hôpital Avicenne, Laboratoire de Virologie, CNR Delta, Bobigny, France. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, HIV Seropositivity, Anti-HIV Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Avicenne and Bichat hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Panzi General Reference Hospital (HGR Panzi) in the Democratic Republic of Congo follows a large number of patients living with HIV-1 (PLWHIV). Although antiretrovirals (ARVs) are available, HIV-1 viral load (HIV-VL) measurement has only been implemented in the hospital since 2018. No data on ARV resistance levels and ARV dosage in plasma have yet been published for this region. We determined the prevalence of virological failure due to ARV resistance amongst patients and assessed the degree of genotypic resistance of the viral strains.

Methods

We performed an HIV-VL test and determined dosage of ARVs on samples collected from 205 PLWHIV at HGR Panzi between 2017 and 2018, including 13 ARV-naive patients. Genotypic resistance testing was performed on all samples with detectable HIV-VLs, and interpreted with the Agence Nationale de Recherches sur le Sida (ANRS) 2018 algorithm.

Results

Baseline resistance to NNRTIs was found in 2 of the 13 treatment-naive individuals (15%). ARV dosage was non-optimal for 44/192 of treated patients (22.9%), with an HIV-VL ≥1000 IU/mL for 40/192 (20.8%) of them. In particular, treatment-experienced viruses presented resistance to at least one NRTI (52.5%), to at least one NNRTIs (70%) or to at least one PIs (15%). Finally, two samples contained viruses with resistance polymorphism in the integrase gene.

Conclusions

The high level of resistance to ARVs observed during this study, mainly due to treatment compliance default, fully justifies the implementation of means for closer patient monitoring. The provision of VL tests and therapeutic education management tools in a PLWHIV follow-up remains an absolute necessity to best adapt the current treatment lines in this region.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsHIV SeropositivityAnti-HIV AgentsHumansDemocratic Republic of the CongoDrug Resistance, ViralAnti-Retroviral AgentsViral Load

Substanzen

Anti-Retroviral AgentsAnti-HIV Agents

Autor:innen und Institutionen

  • APHP, Hôpital Avicenne, Laboratoire de Virologie, CNR Delta, Bobigny, France.
  • Hôpital Général de Référence de Panzi, Université Évangélique en Afrique, Bukavu, DRC.
  • APHP, Hôpital Avicenne, Service des Maladies Infectieuses et Tropicales, Bobigny, France.
  • APHP, Hôpital Bichat, Pharmacology-Toxicology and IAME, UMR 1137, INSERM, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

ORCID-Profile: Minh Patrick Le, Gilles Peytavin, Frédéric Le Gal

Förderung

  • Avicenne and Bichat hospital

Zitieren

APA

Duhant, A., Kusinza, B., Tantet, C., Bisimwa, B., Gare, M., Masemo, B., Alloui, C., Ntakwinjan, M., Mechai, F., Le, M. P., Gerber, A., Muhigirwa, B., Peytavin, G., Gordien, E., Brichler, S., Mukwege, M., & Le Gal, F. (2023). HIV-1 infection in South Kivu (Democratic Republic of Congo): high genotypic resistance to antiretrovirals. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad163

Vancouver

Duhant A, Kusinza B, Tantet C, Bisimwa B, Gare M, Masemo B, et al. HIV-1 infection in South Kivu (Democratic Republic of Congo): high genotypic resistance to antiretrovirals. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad163

BibTeX
@article{Duhant2023,
  author = {Duhant, Alexandra and Kusinza, Byabene and Tantet, Claire and Bisimwa, Basimane and Gare, Mathilde and Masemo, Bihehe and Alloui, Chakib and Ntakwinjan, Mukanire and Mechai, Frédéric and Le, Minh Patrick and Gerber, Athenaïs and Muhigirwa, Balthazar and Peytavin, Gilles and Gordien, Emmanuel and Brichler, Ségolène and Mukwege, Mukengere and Le Gal, Frédéric},
  title = {HIV-1 infection in South Kivu (Democratic Republic of Congo): high genotypic resistance to antiretrovirals},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  doi = {10.1093/jac/dkad163}
}
Kostenlos starten →